ATE401424T1 - Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele - Google Patents

Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele

Info

Publication number
ATE401424T1
ATE401424T1 AT04015822T AT04015822T ATE401424T1 AT E401424 T1 ATE401424 T1 AT E401424T1 AT 04015822 T AT04015822 T AT 04015822T AT 04015822 T AT04015822 T AT 04015822T AT E401424 T1 ATE401424 T1 AT E401424T1
Authority
AT
Austria
Prior art keywords
nucleic acid
tissue targets
acid ligands
cells
ligands
Prior art date
Application number
AT04015822T
Other languages
English (en)
Inventor
Andrew Stephens
Daniel J Schneider
Larry Gold
Ulrich Speck
Original Assignee
Gilead Sciences Inc
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/433,126 external-priority patent/US5688935A/en
Priority claimed from US08/433,124 external-priority patent/US5750342A/en
Application filed by Gilead Sciences Inc, Bayer Schering Pharma Ag filed Critical Gilead Sciences Inc
Application granted granted Critical
Publication of ATE401424T1 publication Critical patent/ATE401424T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3222'-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3517Marker; Tag
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/10Applications; Uses in screening processes
    • C12N2320/13Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04015822T 1995-05-03 1996-05-01 Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele ATE401424T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/433,126 US5688935A (en) 1990-06-11 1995-05-03 Nucleic acid ligands of tissue target
US08/433,124 US5750342A (en) 1990-06-11 1995-05-03 Nucleic acid ligands of tissue target

Publications (1)

Publication Number Publication Date
ATE401424T1 true ATE401424T1 (de) 2008-08-15

Family

ID=27029755

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96915422T ATE276266T1 (de) 1995-05-03 1996-05-01 Nukleinsäureliganden für gewebeziele
AT04015822T ATE401424T1 (de) 1995-05-03 1996-05-01 Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT96915422T ATE276266T1 (de) 1995-05-03 1996-05-01 Nukleinsäureliganden für gewebeziele

Country Status (9)

Country Link
EP (3) EP2000534A3 (de)
JP (1) JPH11504812A (de)
AT (2) ATE276266T1 (de)
AU (1) AU727460B2 (de)
CA (2) CA2641149A1 (de)
DE (2) DE69633386T2 (de)
DK (1) DK1564290T3 (de)
ES (1) ES2310695T3 (de)
WO (1) WO1996034874A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127119A (en) * 1990-06-11 2000-10-03 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands of tissue target
US6346611B1 (en) * 1990-06-11 2002-02-12 Gilead Sciences, Inc. High affinity TGfβ nucleic acid ligands and inhibitors
US6716580B2 (en) 1990-06-11 2004-04-06 Somalogic, Inc. Method for the automated generation of nucleic acid ligands
US6068829A (en) 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
US20070166741A1 (en) 1998-12-14 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US6232287B1 (en) 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
MXPA01007352A (es) * 1999-01-19 2003-06-06 Somalogic Inc Metodo y aparato para la generacion automatizada de ligandos de acido nucleico.
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
AU2775402A (en) * 2001-06-29 2003-01-02 Medimolecular Pty Ltd Nucleic acid ligands to complex targets
US8030465B2 (en) 2001-06-29 2011-10-04 Medimolecular Pty Ltd Nucleic acid ligands to complex targets
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US20110136099A1 (en) 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US8906700B2 (en) 2007-11-06 2014-12-09 Ambergen, Inc. Methods and compositions for phototransfer
EP2078751A1 (de) * 2008-01-11 2009-07-15 Commissariat A L'energie Atomique Spezifische zur Unterdrückung der Zellmigration und -invasion durch Krebszellen erzeugte Aptamere, Verfahren zur Auswahl derartiger Aptamere und ihre Verwendung
EP2159286A1 (de) * 2008-09-01 2010-03-03 Consiglio Nazionale Delle Ricerche Verfahren zur Gewinnung von Oligonucleotid-Aptameren und Verwendungen damit
SG10202006426QA (en) 2013-11-21 2020-08-28 Somalogic Inc Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
EP1493825A3 (de) 1990-06-11 2005-02-09 Gilead Sciences, Inc. Verfahren zur Herstellung von Nukleinsäureliganden
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
JPH06508022A (ja) * 1991-02-21 1994-09-14 ギリアド サイエンシズ,インコーポレイテッド 生体分子に特異的なアプタマーおよび生産方法
IL101038A0 (en) * 1991-02-21 1992-11-15 Gilead Sciences Inc Agent specific for trombin and its use
US5726014A (en) * 1991-06-27 1998-03-10 Genelabs Technologies, Inc. Screening assay for the detection of DNA-binding molecules
AU7102594A (en) * 1993-06-09 1995-01-03 Pharmagenics, Inc. Oligonucleotides which inhibit hiv protease function
AU732961B2 (en) * 1995-05-03 2001-05-03 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US20170110787A1 (en) 2015-10-14 2017-04-20 Apple Inc. Electronic Devices With Millimeter Wave Antennas And Metal Housings

Also Published As

Publication number Publication date
CA2219106A1 (en) 1996-11-07
EP0824540B1 (de) 2004-09-15
AU5720096A (en) 1996-11-21
DK1564290T3 (da) 2008-11-17
DE69633386D1 (de) 2004-10-21
EP1564290B1 (de) 2008-07-16
DE69633386T2 (de) 2005-09-22
AU727460B2 (en) 2000-12-14
EP0824540A1 (de) 1998-02-25
EP1564290A2 (de) 2005-08-17
DE69637605D1 (de) 2008-08-28
CA2641149A1 (en) 1996-11-07
EP2000534A2 (de) 2008-12-10
EP0824540A4 (de) 2003-04-23
EP1564290A3 (de) 2006-02-01
EP2000534A3 (de) 2009-09-02
CA2219106C (en) 2008-09-23
ATE276266T1 (de) 2004-10-15
JPH11504812A (ja) 1999-05-11
ES2310695T3 (es) 2009-01-16
WO1996034874A1 (en) 1996-11-07

Similar Documents

Publication Publication Date Title
ATE401424T1 (de) Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele
DE68907407D1 (de) Verfahren zur sequenzanalyse von dna.
CA2219807A1 (en) Systematic evolution of ligands by exponential enrichment: tissue selex
DE69017346D1 (de) Verfahren zur Hydroformylierung von Olefinen.
DE69915932D1 (de) Verfahren zur Bestimmung von Ziel-Nukleinsäuren
DE68915202D1 (de) Verfahren zur Vermehrung und zum Nachweis von Nukleinsäuresequenzen.
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
ATE191513T1 (de) Verfahren zur amplifikation von nukleinsäuren
DE3689412D1 (de) Verfahren zur durchführung von hybridisierungstests von nukleinsäuren.
DE3483435D1 (de) Verfahren zur durchfuehrung von hybridisierungsreaktionen.
ATE230032T1 (de) Verfahren zur herstellung von festen trägern für hybridisierung und zur verminderung von nichtspezifischem hintergrund
DE69929882D1 (de) Verfahren und vorrichtung zur nukleinsäurereinigung
DE69822348D1 (de) R. b. yun s verfahren zur ausbeutung von tagebaulagerstätten
DE69000784D1 (de) Verfahren zur immobilisierung von schlaedlichen metallen und organischen stoffen.
DE69007649D1 (de) Verfahren zur katalytischen Krackung von Kohlenwasserstoffen.
DE69534217D1 (de) Verfahren zur hemmung von nichtspezifischer hybridisierung in primerverlängerungsreaktionen
DE69524161D1 (de) Verfahren zur Bestimmung von Fibrinogen und Reagenz zu dessen Bestimmung
DE69016879D1 (de) Verfahren zur Reinigung von N-Phosphonmethylglyzin.
DE69008825D1 (de) Verfahren zur Reinigung von Phagen-DNA.
DE68918083D1 (de) Verfahren zur reinigung von blutplasma.
DE69604990D1 (de) Verfahren zur Erhöhung der Katalysatorwirksamkeit bei der Redistribution von Polycarbonat
DE59712415D1 (de) Verfahren zur amplifikation von nukleinsäure
DE3854365D1 (de) Verfahren zur Benetzung von Reiskörnern.
DE69105811D1 (de) Verfahren zur Extraktion von bestimmten Nukleinsäurefragmenten.
DE3789676D1 (de) Diagnostisches Verfahren für Gonorrhoe durch Proben von IgA1-Fragmenten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1564290

Country of ref document: EP

REN Ceased due to non-payment of the annual fee